Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delun Luo

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Signal Transduction and Targeted Therapy|April 17, 2020
Use of a 6-miRNA panel to distinguish lymphoma from reactive lymphoid hyperplasiaJuanjuan Kang, Sisi Yu, Song Lu, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
A novel peptide specifically binding to VEGF receptor suppresses angiogenesis <i>in vitro</i> and <i>in vivo</i>Yuan Zhang, Bifang He, Kun Liu, et al.
Cell Proliferation|January 25, 2023
Tetrahedral framework nucleic acids inhibit pathological neovascularization and vaso-obliteration in ischaemic retinopathy via PI3K/AKT/mTOR signalling pathwayXiaodi Zhou, Yanting Lai, Xiaoxiao Xu, et al.
Cell Proliferation|February 21, 2025
Tetrahedral Framework Nucleic Acid-Based Delivery of DJ-1-saRNA Prevent Retinal Ischaemia-Reperfusion Injury via Inhibiting FerroptosisXianggui Zhang, Zhende Deng, Xiaoxiao Xu, et al.
Materials Today. Bio|December 24, 2025
Sustained suppression of choroidal neovascularization by intraocularly stable tetrahedral network encapsulated miR-22-3pXinyu Liu, You Wang, Junyang Huang, et al.
Ophthalmology|May 6, 2014
Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA studyXiaoxin Li, Gezhi Xu, Yusheng Wang, et al.
Signal Transduction and Targeted Therapy|February 9, 2026
Extraocular delivery of bioswitchable tri-miR-22-loaded tetrahedral DNA nanostructures for intraocular neovascular and neurodegenerative repairQiong Wang, You Wang, Li Chen, et al.
Cell Proliferation|August 1, 2024
Therapeutic effects of tetrahedral framework nucleic acids and tFNAs-miR22 on retinal ischemia/reperfusion injuryXiaoxiao Xu, Yanyan Fu, Delun Luo, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
Correction to: Extraocular delivery of bioswitchable tri-miR-22-loaded tetrahedral DNA nanostructures for intraocular neovascular and neurodegenerative repairQiong Wang, You Wang, Li Chen, et al.
International Journal of Oral Science|November 1, 2022
Advances in regenerative medicine applications of tetrahedral framework nucleic acid-based nanomaterials: an expert consensus recommendationYunfeng Lin, Qian Li, Lihua Wang, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Signal Transduction and Targeted Therapy|April 17, 2020
Use of a 6-miRNA panel to distinguish lymphoma from reactive lymphoid hyperplasiaJuanjuan Kang, Sisi Yu, Song Lu, et al.
Signal Transduction and Targeted Therapy|December 22, 2017
A novel peptide specifically binding to VEGF receptor suppresses angiogenesis <i>in vitro</i> and <i>in vivo</i>Yuan Zhang, Bifang He, Kun Liu, et al.
Cell Proliferation|January 25, 2023
Tetrahedral framework nucleic acids inhibit pathological neovascularization and vaso-obliteration in ischaemic retinopathy via PI3K/AKT/mTOR signalling pathwayXiaodi Zhou, Yanting Lai, Xiaoxiao Xu, et al.
Cell Proliferation|February 21, 2025
Tetrahedral Framework Nucleic Acid-Based Delivery of DJ-1-saRNA Prevent Retinal Ischaemia-Reperfusion Injury via Inhibiting FerroptosisXianggui Zhang, Zhende Deng, Xiaoxiao Xu, et al.
Materials Today. Bio|December 24, 2025
Sustained suppression of choroidal neovascularization by intraocularly stable tetrahedral network encapsulated miR-22-3pXinyu Liu, You Wang, Junyang Huang, et al.
Ophthalmology|May 6, 2014
Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA studyXiaoxin Li, Gezhi Xu, Yusheng Wang, et al.
Signal Transduction and Targeted Therapy|February 9, 2026
Extraocular delivery of bioswitchable tri-miR-22-loaded tetrahedral DNA nanostructures for intraocular neovascular and neurodegenerative repairQiong Wang, You Wang, Li Chen, et al.
Cell Proliferation|August 1, 2024
Therapeutic effects of tetrahedral framework nucleic acids and tFNAs-miR22 on retinal ischemia/reperfusion injuryXiaoxiao Xu, Yanyan Fu, Delun Luo, et al.
Signal Transduction and Targeted Therapy|April 28, 2026
Correction to: Extraocular delivery of bioswitchable tri-miR-22-loaded tetrahedral DNA nanostructures for intraocular neovascular and neurodegenerative repairQiong Wang, You Wang, Li Chen, et al.
International Journal of Oral Science|November 1, 2022
Advances in regenerative medicine applications of tetrahedral framework nucleic acid-based nanomaterials: an expert consensus recommendationYunfeng Lin, Qian Li, Lihua Wang, et al.
Pageof 2